Quick Answer
Tectonic Therapeutic, Inc. reported Cash And Cash Equivalents At Carrying Value of $253.80 million for the year ending 2025.
- Tectonic Therapeutic, Inc. showed an increase of +79.7% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Tectonic Therapeutic, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: $57.93 million | Q2 2018: $154.99 million | Q3 2018: $138.55 million | Q1 2019: $108.48 million | Q2 2019: $90.35 million | Q3 2019: $206.36 million | Q1 2020: $257.70 million | Q2 2020: $244.38 million | Q3 2020: $219.55 million | Q1 2021: $233.03 million | Q2 2021: $226.44 million | Q3 2021: $201.37 million | Q1 2022: $161.66 million | Q2 2022: $132.41 million | Q3 2022: $115.97 million | Q1 2023: $72.33 million | Q2 2023: $14.93 million | Q3 2023: $6.33 million | Q1 2024: $18.75 million | Q2 2024: $185.12 million | Q3 2024: $159.10 million | Q1 2025: $306.25 million | Q2 2025: $287.38 million | Q3 2025: $268.44 million.
- Over the full 9 years of available data (2017 to 2025), Tectonic Therapeutic, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 4,156.2%.
- Historical annual values: Fiscal year 2025: $253.80 million | Fiscal year 2024: $141.24 million | Fiscal year 2023: $28.77 million | Fiscal year 2022: $92.56 million | Fiscal year 2021: $189.57 million | Fiscal year 2020: $259.68 million | Fiscal year 2019: $187.04 million | Fiscal year 2018: $126.30 million | Fiscal year 2017: $5.96 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: